Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use (original) (raw)
Abstract.
Dendritic cells (DC) have been shown to be efficient antigen-presenting cells (APC) and, as such, could be considered ideal candidates for cancer immunotherapy. Immature DC (iDC) efficiently capture surrounding antigens; however, only mature DC (mDC) prime naive T lymphocytes. Clinical trials using DC-based tumor vaccines have achieved encouraging, but limited, success, possibly due to the use of immature or incompletely mature DC. Thus, it was apparent that a method capable of generating large numbers of fully functional iDC, their pulsing with desired form of tumor antigens and the subsequent complete and reproducible maturation of iDC is needed. Therefore, we compared two different methods of producing large numbers of iDC. Both protocols yielded comparable numbers of cells with an iDC phenotype with phagocytic function. We next determined which of the clinically applicable activators could induce the complete and reproducible maturation of DC, in order to define the most suitable combination for future clinical trials. Only a combination of TNFα + Poly (I:C), or a previously described cytokine cocktail of TNFα + IL-1β + IL-6 + prostaglandin E2, induced the complete activation of the whole DC population, as assessed by the cell surface expression of CD83 and costimulatory molecules. The matured DC were functionally superior to iDC in their ability to stimulate the proliferation of allogeneic lymphocytes and autologous keyhole limpet hemocyanin (KLH)-specific T lymphocytes. Furthermore, only the combination of TNFα + Poly (I:C) activated DC to produce large amounts of biologically active p70 IL-12. Thus DC maturation by TNFα + Poly (I:C) could efficiently bias T cell response towards Th1 response. Implementation of our results into clinical protocols used for DC generation could be beneficial for future immunotherapy trials.
Access this article
Subscribe and save
- Starting from 10 chapters or articles per month
- Access and download chapters and articles from more than 300k books and 2,500 journals
- Cancel anytime View plans
Buy Now
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Instant access to the full article PDF.
Similar content being viewed by others
Author information
Authors and Affiliations
- INSERM U419, Institut de Biologie, 9 Quai Moncousu, 44093, Nantes, Cedex 1, France, , , , ,
Radek Spisek, Laurent Bretaudeau, Isabelle Barbieux, Khaled Meflah & Marc Gregoire
Authors
- Radek Spisek
- Laurent Bretaudeau
- Isabelle Barbieux
- Khaled Meflah
- Marc Gregoire
Additional information
Electronic Publication
Rights and permissions
About this article
Cite this article
Spisek, R., Bretaudeau, L., Barbieux, I. et al. Standardized generation of fully mature p70 IL-12 secreting monocyte-derived dendritic cells for clinical use.Cancer Immunol Immunother 50, 417–427 (2001). https://doi.org/10.1007/s002620100215
- Received: 03 May 2001
- Accepted: 28 June 2001
- Issue date: October 2001
- DOI: https://doi.org/10.1007/s002620100215